Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John McConville

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|January 11, 2025
C5 complement inhibition and FcRn modulation in generalized myasthenia gravis. Fast-acting but short-lived therapies the use of which should prompt assertive escalation of conventional treatmentsJohn McConville
Current Opinion in Pharmacology|May 22, 2002
Diseases of the neuromuscular junctionJohn McConville, Angela Vincent
Neurology|January 26, 2005
Is "seronegative" MG explained by autoantibodies to MuSK?Angela C Vincent, John McConville, John Newsom-Davis
The Lancet. Neurology|July 10, 2003
Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targetsAngela Vincent, John Bowen, John Newsom-Davis, et al.
Seminars in Neurology|July 2, 2004
Seronegative myasthenia gravisAngela Vincent, John McConville, Maria Elena Farrugia, et al.
Journal of Neuroimmunology|April 19, 2002
Thymic myoid cells and germinal center formation in myasthenia gravis; possible roles in pathogenesisIoannis Roxanis, Kingsley Micklem, John McConville, et al.
BMC Neurology|June 23, 2010
A systematic review of population based epidemiological studies in Myasthenia GravisAisling S Carr, Chris R Cardwell, Peter O McCarron, et al.
Perspectives on Medical Education|November 4, 2017
Standardized residency training in China: the new internal medicine curriculumJonathan Lio, Yanqing Ye, Hongmei Dong, et al.
The Ulster Medical Journal|February 10, 2023
A Neurology Advanced Referral Management System (NARMS) Reduces Face-to-Face Consultations By Over Sixty PercentJohn McConville, Annemarie Hunter, Ailsa Fulton, et al.
Journal of Personalized Medicine|September 23, 2022
The Role of Sphingomyelin and Ceramide in Motor Neuron DiseasesGavin McCluskey, Colette Donaghy, Karen E Morrison, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Journal of Neurology, Neurosurgery, and Psychiatry|January 11, 2025
C5 complement inhibition and FcRn modulation in generalized myasthenia gravis. Fast-acting but short-lived therapies the use of which should prompt assertive escalation of conventional treatmentsJohn McConville
Current Opinion in Pharmacology|May 22, 2002
Diseases of the neuromuscular junctionJohn McConville, Angela Vincent
Neurology|January 26, 2005
Is "seronegative" MG explained by autoantibodies to MuSK?Angela C Vincent, John McConville, John Newsom-Davis
The Lancet. Neurology|July 10, 2003
Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targetsAngela Vincent, John Bowen, John Newsom-Davis, et al.
Seminars in Neurology|July 2, 2004
Seronegative myasthenia gravisAngela Vincent, John McConville, Maria Elena Farrugia, et al.
Journal of Neuroimmunology|April 19, 2002
Thymic myoid cells and germinal center formation in myasthenia gravis; possible roles in pathogenesisIoannis Roxanis, Kingsley Micklem, John McConville, et al.
BMC Neurology|June 23, 2010
A systematic review of population based epidemiological studies in Myasthenia GravisAisling S Carr, Chris R Cardwell, Peter O McCarron, et al.
Perspectives on Medical Education|November 4, 2017
Standardized residency training in China: the new internal medicine curriculumJonathan Lio, Yanqing Ye, Hongmei Dong, et al.
The Ulster Medical Journal|February 10, 2023
A Neurology Advanced Referral Management System (NARMS) Reduces Face-to-Face Consultations By Over Sixty PercentJohn McConville, Annemarie Hunter, Ailsa Fulton, et al.
Journal of Personalized Medicine|September 23, 2022
The Role of Sphingomyelin and Ceramide in Motor Neuron DiseasesGavin McCluskey, Colette Donaghy, Karen E Morrison, et al.
Pageof 4